Pathophysiology of clinical symptoms of malaria: Role of cytokines, cytoadherence and premunition;Physiopathologie des symptômes du paludisme: Rôle des cytokines, de la cytoadhérence et de la prémunition

Presse Medicale

Volumn 25, Issue 2, 1996, Pages 70-76

  Hommel, M ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

CELL ADHESION; HUMAN; IMMUNITY; MALARIA; PATHOPHYSIOLOGY; REVIEW; SYMPTOMATOLOGY; ERYTHROCYTE; HOST PARASITE INTERACTION; IMMUNOLOGY; PARASITOLOGY; PHYSIOLOGY;

CELL ADHESION; CYTOKINES; ERYTHROCYTES; HOST-PARASITE RELATIONS; HUMANS; MALARIA;

EID: 0030594044     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Ambroise-Thomas P, Carnevale P, Félix H, Mouchet J. Le paludisme. Encyclopédie Médico-Chirurgicale 1984;89:A10.
2. Touze JE, Baudon D, Martet G. Difficultés diagnostiques et aspects actuels du paludisme à Plasmodium falciparum au retour d'une zone de chimiorésistance. Presse Med 1988;31:1573-5.
3. Taylor TE, Molyneux ME, Wirima JJ, Fletcher KA, Morris K. Blood glucose levels in Malawian children before and during the administration of intravenous quinine for severe falciparum malaria N Engl J Med 1988;319:1040-7.
4. Arese P, Turini F, Ginsburg H. Erythrophagocytosis in malaria: host defence or menace to the macrophage. Parasitol Today 1991;7:25-8.
5. Clark IA, Chaudri G, Cowden WB. Role of tumour necrosis factor in the illness and pathology of malaria. Trans R Soc Trop Med Hyg 1989;83:436-40.
6. Karunaweera ND, Grau GE, Gamage P, Carter R, Mendis KN. Dynamics of fever and serum levels of tumour necrosis factor are closely associated during clinical paroxysms in Plasmodium vivax malaria. Proc Natl Acad Sci USA 1992; 89:3200-3.
7. Grau GE, Taylor TE, Molyneux ME et al. Tumour necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 1989;320:1586-91.
8. Kern P, Hemmer GJ, Van Damme J, Gruss HJ, Dietrich M. Elevated tumour necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. Am J Med 1989;57.139-43.
9. Kwiatkowski D, Molyneux ME, Stephens S et al. Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med 1993;86:91-8.
10. Bate CAW, Taverne J, Roman E, Moreno C, Playfair JHL. TNF induction by malaria exoantigens depends on phospholipid. Immunology 1991;75:129-35
11. Grau GE, Kindler V, Piguet PF, Lambert PH, Vassali P. Prevention of experimental cerebral malaria by anticytokine antibodies. IL-3 and GM-CSF are intermediates in increased TNF production and macrophage accumulation. J Exp Med 1988,168:1499-504.
12. Ho M, Tongstawe P, Kriangkum J et al. Polyclonal expansion of peripheral γδ T cells in human Plasmodium falciparum malaria. Infect Immun 1994;62:855-62.
13. Mendis KH, Naotunne T de S, Karunaweera ND, Del Giudice G, Grau GE, Carter R. Anti-parasite effects of cytokines. Immunol Lett 1990,25:217-20.
14. Rockett KA, Awburn MM, Rockett EJ, Clark IA. Tumor necrosis factor and interleukin-1 synergy in the context of malaria pathology. Am J Trop Med Hyg 1994;50:735-42.
15. Clark IA. Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis? Lancet 1978;ii:75-7
16. Means RT. Pathogenesis of the anemia of chronic diseases: a cytokine-mediated anemia. Stem Cells 1994,13:32-7.
17. Weatherall DJ. The anaemia of malaria. In: Malaria: principles and practice of malariology. Wernsdorfer WH, MacGregor I eds. Churchill Linvingstone 1988; 1:735-51.
18. White NJ, Ho M. The pathophysiology of malaria. Adv Parasitol 1992,31:83-173.
19. Molyneux ME, Taylor TE, Wirima JJ, Borgstein J. Clinical features and prognosis indicators in paediatric cerebral malaria: a study of 131 comatose malawian children Q J Med 1989;71:441-51.
20. Newton CR, Kirkham FJ, Winstanley P. Intracranial pressure in African children with cerebral malaria. Lancet 1991;337:573-6.
21. Taylor K, Bate CAW, Carr RE, Butcher GA, Taverne J, Playfair JHL. Phospholipid containing toxic malaria antigens induce hypoglycemia. Clin Exp Immunol 1992;90:1-5.
22. White NJ. Pathophysiology. In. Clinics in tropical medicine and communicable diseases Malaria, Strickland GT ed. W.B. Saunders Company 1986.55-90.
23. Dei-Cas E. Anatomie pathologique du paludisme. In: Paludisme, Danis M, Mouchet J, eds Ellipse/Aupelf, Paris 1991:60-5.
24. Warrell DA. Pathophysiology of severe falciparum malaria in man Parasitology 1987;94 (suppl.).S53-76.
25. Newton CR, Peshu N, Kendall B et al. Brain swelling and ischaemia in Kenyans with cerebral malaria Arch Dis Child 1994;70:281-7.
26. MacPherson G, Warrell MJ, White NJ, Looareesuwan S, Warrell DA. Human cerebral malaria: a quantitative ultrastructural analysis of parasitized erythrocytes Am J Pathol 1985;119:385-401.
27. Riganti M, Pongponratn E, Tegoshi T, Looareesuwan S, Punpoowong B, Aikawa M. Human cerebral malaria in Thailand: a clinicopathological correlation. Immunol Lett 1990;25.199-206.
28. Hommel M. Amplification of cytoadherence in cerebral malaria: towards a more rational explanation of disease pathophysiology. Ann Trop Med Parasitol 1993; 87:627-35.
29. Mshana RN, Boulandi J, Mshana MN, Mayombo J, Mendome G. Cytokines in the pathogenesis of malaria: levels of IL-1β, IL-4, IL-6, TNF-α, and IFN-γ in plasma of healthy individuals and malaria patients in a holoendemic area. J Clin Lab Immunol 1994;34:131-9.
30. Eckwalanga M, Marussig M, Tavares MD et al. Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology. Proc Natl Acad Sci USA 1994; 91:8097-101.
31. Clark IA, Rockett KA, Cowden WB. Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet 1992;340:894-6.
32. Hommel M, Semoff S. Expression and function of erythrocyte-associated surface antigens in malaria. Biol Cell 1988;64:183-203.
33. Hommel M, David PH, Oligino LD. Surface alterations of erythrocytes in Plasmodium faciparum malaria. Antigenic variation, antigenic diversity and role of the spleen. J Exp Med 1983;157:1137-48.
34. Roberts DJ, Craig AG, Berendt AR et al Rapid switching to multiple antigenic and adhesive phenotypes in malaria. Nature 1992;357:689-92.
35. Hommel M. Cytoadherence of malaria-infected erythrocytes. Bloods Cells 1990; 16:605-19.
36. Carlsson J, Helmby H, Hill AVS, Brewster D, Greenwood BM, Wahlgren M. Human cerebral malaria-association with erythrocyte resetting and lack of anti-rosetting antibodies. Lancet 1990;ii:1457-60.
37. Ockenhouse CF, Tegosho T, Maeno Y et al. Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. J Exp Med 1992;176:1183-9.
38. Jeffery GM. Epidemiological significance of repeated infections with homologous and heterologous strains and species of Plasmoduim. Bull W H O 1966;35:873-82.
39. Hommel M. The role of variant antigens in acquired immunity to Plasmodium falciparum. Am Soc Belg Med Trop 1985;65 (suppl.2):57-67.
40. Aikawa M, Brown A, Smith CD et al. A primate model for human cerebral malaria: Plasmodium coatneyi-infected rhesus monkeys. Am J Trop Med Hyg 1992; 46:391-7.
41. Turner GD, Morrisson G, Jones M et al. An immunohistochemical study of the pathology of fatal malaria. Evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration. Am J Pathol 1994;145:1057-69.
42. Jakobsen PH, Morris-Jones S, Hviid L et al. Increased plasma concentrations of sICAM-1, sVCAM-1 and sELAM-1 in patients with Plasmodium falciparum or P. vivax malaria and association with disease severity. Immunology 1994; 83:665-9.
43. Allan RJ, Rowe A, Kwiatkowski D. Plasmodium falciparum varies in its ability to induce tumor necrosis factor. Infect Immun 1993;61:4772-6.
44. Rest JR. Cerebral malaria in inbred mice. I. A new model and its pathology. Trans R Soc Trop Med Hyg 1982;76:410-15.
45. Cox J, Semoff S, Hommel M. Plasmodium chabaudi: a rodent malaria model for in vivo and in vitro cytoadherence of malaria parasites in the absence of knobs. Parasite Immunol 1987;9:543-61.
46. Dennison JMT, Hommel M. Cerebral sequestration of murine malaria parasites after receptor amplification in mixed infections. Ann Trop Med Parasitol 1993; 87:665.
47. Cruz Cubas AB, Ballet JJ, Gentilini M, Montjour L. Immunité à médiation cellulaire et protection contre les stades sanguins de Plasmodium falciparum. Presse Med 1993;22:1967-73.
48. Hill AVS. Malaria resistance genes: a natural selection. Trans R Soc Trop Med Hyg 1992;86:225-6.
49. Marsh K, Greenwood BM. The immunopathology of malaria. In: Clinics in tropical medicine and communicable diseases. Malaria, Strickland GT ed. W.B. Saunders Company 1986:91-126.
50. Sergent E, Parrot L, Donatien A. Une question de terminologie : immuniser et prémunir. Bull Soc Pathol Exot 1924;17:37-8.
51. Miller MF. Observations on the natural history of malaria in semi-resistant West Africans. Trans R Soc Trop Med Hyg 1958;52:152-68.
52. Garg B, Tayior TE, Hommel M, Molyneux ME. Inverse relationship between antimalarial antibody titres and tumour necrosis factor concentrations in severe malaria in African children. Ann Trop Med Parasitol 1995;89:177.
53. Bate CAW, Kwiatkowski D. Inhibitory immunoglobulin M antibodies to tumour necrosis factor-inducing toxins in patients with malaria. Infect Immun 1994; 62:3086-91.
54. Playfair JHL, Taverne J, Bate CAW, De Souza JB. The malaria vaccine: anti-parasite or anti-disease? Immunol Today 1990;11:25-7.